Target intelligence / Profile preview

Oxidized form of endogenous antioxidant

Molecular classification
Metabolite, Reactive species, Small molecule
01

Overview

Oxidized forms of endogenous antioxidants are the chemical products generated when cellular antioxidants, such as glutathione (GSH), vitamin C (ascorbic acid), and vitamin E (tocopherol), neutralize reactive oxygen species (ROS) or reactive nitrogen species (RNS) (Smith et al., 2004; Packer et al., 2001). Key examples include glutathione disulfide (GSSG), dehydroascorbic acid (DHA), and tocopheryl radicals. In healthy cells, these oxidized species are rapidly recycled back to their reduced, active forms by enzymatic systems like glutathione reductase and thioredoxin reductase to maintain redox homeostasis (StatPearls, 2023). However, an accumulation of these oxidized forms is a hallmark of oxidative stress and is associated with the pathophysiology of various diseases, including type 2 diabetes, neurodegenerative disorders, and cardiovascular conditions (NIH, 2022). Therapeutic agents like alpha-lipoic acid (ALA) and N-acetylcysteine (NAC) aim to restore the antioxidant balance by directly reducing these oxidized forms or providing the necessary precursors and cofactors for their enzymatic regeneration (PubChem, 2024).

Other names
Oxidized endogenous antioxidantsAntioxidant radicalsDehydroascorbic acidGlutathione disulfideTocopheryl quinoneOxidized redox couples
02

Mechanism of action

Drugs targeting these oxidized forms typically act as reducing agents or cofactors for recycling enzymes, facilitating the conversion of oxidized antioxidants (e.g., GSSG, dehydroascorbic acid) back into their active, reduced states (e.g., GSH, ascorbic acid) to restore cellular antioxidant capacity (Smith et al., 2004; Packer et al., 2001).

03

Biological functions

Redox homeostasisOxidative stress signalingMetabolic byproduct
04

Disease associations

Diabetes mellitusNeurodegenerative diseaseCardiovascular diseaseInflammationCancer
05

Safety considerations

Antioxidant paradox (pro-oxidant effects at high doses)Interference with physiological ROS-mediated signaling pathwaysPotential for reductive stressBioavailability and metabolic stability of exogenous reducers
06

Interacting drugs

Alpha-lipoic acid

4 more in the full profile.

07

Biomarkers

GSH/GSSG ratioDehydroascorbic acid (DHA) levelsProtein carbonyls8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)

Beyond the preview

Go deeper on Oxidized form of endogenous antioxidant.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidized form of endogenous antioxidant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call